Will elevated levels of plasminogen interfere with the Chromogenix Coamatic® Plasmin Inhibitor test?
No, elevated plasminogen levels should not effect the results. Residual plasmin hydrolyzes the chromogenic substrate, but the principle of plasminogen is different. No part is played by plasmin. Instead, determination by chromogenic substrate requires all plasminogen in the sample to be activated to plasminogen/streptokinase complex, which hydrolyzes the chromogenic substrate.
Coamatic® Plasmin Inhibitor (discontinued) is not influenced by alpha2-macroglobulin up to 9 mmol/l, which is approximately three times higher than the normal level in human plasma.
Run a blank and subtract it from your sample values. The sample blank activity is determined following the method procedure by substituting the plasmin working solution with a mixture containing 1 volume of plasmin solvent and 1.5 volumes of working buffer.
What clinical situations are associated with decreased levels of plasmin inhibitor? Elevated levels?
Congenital deficiencies are characterized by bleeding occurring some hours after the initial injury. Clotting and wound healing are usually normal, but the hemostatic plug is defective and breaks down prematurely. As a result of liver diseases and DIC, decreased levels of plasmin inhibitor can be observed. Increased levels of plasmin inhibitor have been reported during post-operative episodes.
Describe the measurement principle behind the discontinued Chromogenix Coamatic® Plasmin Inhibitor kit.
Incubation of diluted plasma with an excess of plasmin results in a rapid complex formation between functional plasmin inhibitor present in the plasma and plasmin. The inhibited plasmin activity is proportional to the amount of plasmin inhibitor. The remaining amount of plasmin hydrolyzes the chromogenic substrate S-2403™, thus liberating the chromophoric group pNA.
alpha2-antiplasmin is a synonym for plasmin inhibitor, which, as the name implies, is a fast-acting inhibitor of the fibrinolytic system. Plasmin Inhibitor binds with plasmin, forming a stable complex devoid of proteolytic activity. Plasmin inhibitor can also form a reversible complex with the lysine-binding sites of plasminogen, as can histidine-rich glycoprotein (HRG), which has an inhibitory effect on the binding of plasminogen to fibrin.
|Protein S||70||10 (free)||0.14|
|Heparin Cofactor II||66||80||1.2|
|Protein C Inhibitor||57||4||0.07|